Breast cancer chemotherapy Journal Article


Authors: Mcarthur, H. L.; Hudis, C. A.
Article Title: Breast cancer chemotherapy
Abstract: Chemotherapy can be an integral component of the adjuvant management strategy for women with early-stage breast cancer. Modern adjuvant strategies now comprises one or more chemotherapy agents, hormonal maneuvers, immunotherapy agents, or experimental agents. The use of adjuvant chemotherapy is generally based on estimates of an individuals risk of recurrence and the expected benefit of therapy. However, risk-benefit calculations have recently become increasingly sophisticated as a result of advances in genetic testing and molecular marker identification as well as ongoing refinements in chemotherapy strategies. In this article we will review the role of important prognostic and predictive factors and the rationale for adjuvant systemic therapy and modern chemotherapy regimens in the management of women with early-stage breast cancer. © 2007 Lippincott Williams & Wilkins.
Keywords: cancer chemotherapy; clinical trial; neutropenia; review; doxorubicin; fluorouracil; cancer combination chemotherapy; cancer risk; antineoplastic agents; pathophysiology; paclitaxel; cancer adjuvant therapy; chemotherapy, adjuvant; chemotherapy; methotrexate; cancer staging; methodology; antineoplastic agent; neoplasm staging; multiple cycle treatment; breast cancer; gene expression; mastectomy; tumor volume; epidermal growth factor receptor 2; tumor markers, biological; cyclophosphamide; breast neoplasms; tumor marker; histology; cancer mortality; risk; docetaxel; asthenia; drug dose escalation; febrile neutropenia; add on therapy; adjuvant chemotherapy; cardiotoxicity; breast tumor; tamoxifen; predictor variable; epirubicin; taxane derivative; estrogen receptor; trastuzumab; anastrozole; navelbine; antibiotics, antineoplastic; anthracycline; antineoplastic antibiotic; management; calculation; adjuvant; hypersensitivity; early stage
Journal Title: The Cancer Journal
Volume: 13
Issue: 3
ISSN: 1528-9117
Publisher: Lippincott Williams & Wilkins  
Date Published: 2007-05-01
Start Page: 141
End Page: 147
Language: English
DOI: 10.1097/PPO.0b013e318074dc6f
PUBMED: 17620762
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 17 November 2011" - "CODEN: CAJOC" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis